Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new page revision line shows Revision: v3.6.6 (replacing v3.6.5) at the bottom of the study record, indicating a newer release of the page. This update appears to be a metadata/version update and does not modify the study data or eligibility details.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, signaling a new version of the ClinicalTrials.gov page. This change represents a backend update rather than a modification to the study details or eligibility criteria.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision was updated from v3.6.3 to v3.6.4, indicating a maintenance update to the page's record.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision stamp was updated from v3.6.2 to v3.6.3. This indicates a minor backend update rather than changes to study details or user-facing content.SummaryDifference0.1%

- Check77 days agoChange DetectedUpdated the page revision from v3.6.0 to v3.6.2, indicating a minor metadata update to the study details page. This change does not alter the study data or user-facing content.SummaryDifference0.1%

- Check91 days agoChange DetectedThe study page now includes sponsor and collaborating institution details (Alona Zer and Rabin Medical Center) and updates metadata with Last Verified and a new Revision: v3.6.0. New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label formatting was standardized.SummaryDifference2%

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.